Skip to content
value.today
Total raised
$122 M
8 rounds on record
Latest round
$5 M
Oct 2018
First round on record
Aug 2010
Today
Private
No later event on record

Funding rounds

8 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Myoscience Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2018$5 MNo. 8$2 to $10 million

Myoscience Inc.: Raise no. 8, Oct 2018

Investors in this round

4 investors had bought by the notice of Nov 13, 2018: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sam Mawn-Mahlau · Executive Officer · Assistant Corporate Secretary
  • Timothy Still · Executive Officer, Director · CEO
  • Anthony Lando · Director
  • Bernard Coulie · Director
  • Brian Farley · Director
  • Darnard Guillaume · Director
  • Jan Pansaert · Director
  • Jon Serbousek · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Multiple Closings”

Signed by Sam Mawn-Mahlau, Assistant Corporate Secretary. Source: SEC Form D, newest notice filed Nov 13, 2018. Read the notice at the SEC.

debt, optionsSEC
Mar 2018$31 MNo. 7$10 to $50 million

Myoscience Inc.: Raise no. 7, Mar 2018

Investors in this round

17 investors had bought by the notice of Mar 7, 2018: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$31 M of $41 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cary Vance · Executive Officer, Director · CEO
  • John Supan · Executive Officer · CFO
  • Sam Mawn-Mahlau · Executive Officer · Assistant Corporate Secretary
  • Anthony Lando · Director
  • Bernard Coulie · Director
  • Guillaume Darnard · Director
  • Jan Pensaert · Director
  • Jon Serbousek · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Payment in part by cancellation of indebtedness”

Signed by Sam Mawn-Mahlau, Assistant Corporate Secretary. Source: SEC Form D, newest notice filed Mar 7, 2018. Read the notice at the SEC.

equity, optionsSEC
Nov 2016$14 MNo. 6$10 to $50 million

Myoscience Inc.: Raise no. 6, Nov 2016

Investors in this round

2 investors had bought by the notice of Oct 18, 2017: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $21 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cary Vance · Executive Officer · CEO
  • Sam Mawn-Mahlau · Executive Officer · Assistant Corporate Secretary
  • Anthony Lando · Director
  • Bernard Coulie · Director
  • Guillaume Darnard · Director
  • Jan Pensaert · Director
  • Jon Serbousek · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amount was increased from $10,000,000 to $21,000,000”

Signed by Sam Mawn-Mahlau, Assistant Secretary. Source: SEC Form D and 1 amendment, newest notice filed Oct 18, 2017. Read the notice at the SEC.

equitySEC
Jul 2014$8 MNo. 5$2 to $10 million

Myoscience Inc.: Raise no. 5, Jul 2014

Investors in this round

28 investors had bought by the notice of Sep 26, 2014: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $12 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeffrey M. Gold · Executive Officer
  • Jesse D. Rosen · Executive Officer
  • John M. Allison · Executive Officer
  • Justin M. Chickles · Executive Officer
  • Peter M. Osborne · Executive Officer
  • Richard M. Ferrari · Executive Officer, Director
  • Tracy M. Henry · Executive Officer
  • Edwin D. Snape · Director
  • James M. Hawkins · Director
  • Remmert M. Laan · Director
  • Rudi M. Marien · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard M. Ferrari, Interim CEO. Source: SEC Form D, newest notice filed Sep 26, 2014. Read the notice at the SEC.

debt, optionsSEC
Sep 2013$10 MNo. 4$10 to $50 million

Myoscience Inc.: Raise no. 4, Sep 2013

Investors in this round

35 investors had bought by the notice of Oct 9, 2013: 35 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $25 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bill Brodie · Executive Officer
  • Clint Carnell · Executive Officer, Director
  • John Allison · Executive Officer
  • Peter M. Osborne · Executive Officer
  • Tracy M. Henry · Executive Officer
  • Edwin M. Snape · Director
  • Remmert M. Laan · Director
  • Richard M. Ferrari · Director
  • Rudi M. Marien · Director
  • Thomas D. Weldon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Peter Osborne, Secretary. Source: SEC Form D, newest notice filed Oct 9, 2013. Read the notice at the SEC.

equitySEC
Mar 2012$33 MNo. 3$10 to $50 million

Myoscience Inc.: Raise no. 3, Mar 2012

Investors in this round

32 investors had bought by the notice of Apr 2, 2012: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$33 M of $45 M offered; $12 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$643,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks finders' fees as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Clint Carnell · Executive Officer, Director
  • Robert Grant · Executive Officer, Director
  • Edwin Snape · Director
  • Jeffrey Nugent · Director
  • Joe Whitters · Director
  • Lisa Elkins · Director
  • Richard Ferrari · Director
  • Thomas Weldon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • American Equities Overseas, Inc. · Zurich, SwitzerlandSold in no state named, and outside the US

Remarks in the notice

  • On fees: “This amount is an estimate, and does not include reasonable out-of-pockets expenses which will also be reimbursed. Of the fee mentioned herein, roughly half will be paid in cash and roughly half will be issued in the form of warrants.”
  • On the amounts: “The actual total offering amount: $44,999,999.76”

Signed by Clint Carnell, Ceo. Source: SEC Form D, newest notice filed Apr 2, 2012. Read the notice at the SEC.

equitySEC
Mar 2011$19 MNo. 2$10 to $50 million

Myoscience Inc.: Raise no. 2, Mar 2011

Investors in this round

35 investors had bought by the notice of Mar 16, 2011: 35 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $26 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kristine M. Tatsutani · Executive Officer
  • Matthew M. Franklin · Executive Officer
  • Mike M. Fourkas · Executive Officer
  • Robert M. Curtis · Executive Officer, Director
  • Jeffrey M. Nugent · Director
  • Joe M. Whitters · Director
  • Lisa M. Elkins · Director
  • Richard M. Ferrari · Director
  • Robert M. Grant · Director
  • Thomas E. Hancock · Director
  • Thomas M. Weldon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount: $26,160,000.00 Total Amount Sold: $18,758,617.20 Total Remaining to be Sold: $7,401,382.80”

Signed by Robert M. Curtis, President & CEO. Source: SEC Form D, newest notice filed Mar 16, 2011. Read the notice at the SEC.

equitySEC
Aug 2010$2 MNo. 1$2 to $10 million

Myoscience Inc.: Raise no. 1, Aug 2010

Investors in this round

8 investors had bought by the notice of Aug 30, 2010: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kristine M. Tatsutani · Executive Officer
  • Matthew M. Franklin · Executive Officer
  • Mike M. Fourkas · Executive Officer
  • Robert M. Curtis · Executive Officer, Director
  • Jeffrey M. Nugent · Director
  • Joe M. Whitters · Director
  • John M. Deedrick · Director
  • Lisa M. Elkins · Director
  • Richard M. Ferrari · Director
  • Thomas E. Hancock · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount: $3,000,000.00; Total Amount Sold: $2,199,975.18; Total Remaining to be Sold: $800,024.82”

Signed by Robert M. Curtis, President & CEO. Source: SEC Form D, newest notice filed Aug 30, 2010. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Myoscience Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2018).

    SEC Form D · Nov 2018

  • The industry group it chose in its notices: Other.

    SEC Form D · Nov 2018

That is all the official record says: Myoscience Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Myoscience Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 8 rounds above had up to 35 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Myoscience Inc.
NameRoleNamed in
Sam Mawn-MahlauAssistant Corporate SecretaryNov 2018
Timothy StillCEONov 2018
Cary VanceCEOMar 2018
John SupanCFOMar 2018
Tracey HenryGeneral ManagerDec 2016
Jeffrey M. GoldExecutive officerSep 2014
Jesse D. RosenExecutive officerSep 2014
John M. AllisonExecutive officerSep 2014
Justin M. ChicklesExecutive officerSep 2014
Peter M. OsborneExecutive officerSep 2014
Richard M. FerrariExecutive officerSep 2014
Tracy M. HenryExecutive officerSep 2014
Bill BrodieExecutive officerOct 2013
Clint CarnellExecutive officerOct 2013
John AllisonExecutive officerOct 2013
Robert GrantExecutive officerApr 2012
Kristine M. TatsutaniExecutive officerMar 2011
Matthew M. FranklinExecutive officerMar 2011
Mike M. FourkasExecutive officerMar 2011
Robert M. CurtisExecutive officerMar 2011
Anthony LandoDirectorNov 2018
Bernard CoulieDirectorNov 2018
Brian FarleyDirectorNov 2018
Darnard GuillaumeDirectorNov 2018
Jan PansaertDirectorNov 2018
Jon SerbousekDirectorNov 2018
Timothy StillCEONov 2018
Cary VanceCEOMar 2018
Guillaume DarnardDirectorMar 2018
Jan PensaertDirectorMar 2018
Rudi MarienDirectorDec 2016
Edwin D. SnapeDirectorSep 2014
James M. HawkinsDirectorSep 2014
Remmert M. LaanDirectorSep 2014
Richard M. FerrariDirectorSep 2014
Rudi M. MarienDirectorSep 2014
Clint CarnellDirectorOct 2013
Edwin M. SnapeDirectorOct 2013
Thomas D. WeldonDirectorOct 2013
Edwin SnapeDirectorApr 2012